AR082907A1 - Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner) - Google Patents
Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner)Info
- Publication number
- AR082907A1 AR082907A1 ARP110103250A ARP110103250A AR082907A1 AR 082907 A1 AR082907 A1 AR 082907A1 AR P110103250 A ARP110103250 A AR P110103250A AR P110103250 A ARP110103250 A AR P110103250A AR 082907 A1 AR082907 A1 AR 082907A1
- Authority
- AR
- Argentina
- Prior art keywords
- matrix
- transdermal therapeutic
- crystallization
- inhibitant
- release liner
- Prior art date
Links
- 238000002425 crystallisation Methods 0.000 title abstract 2
- 230000008025 crystallization Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 abstract 7
- 239000004480 active ingredient Substances 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000002356 single layer Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010040299A DE102010040299A1 (de) | 2010-09-06 | 2010-09-06 | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082907A1 true AR082907A1 (es) | 2013-01-16 |
Family
ID=44653285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110103250A AR082907A1 (es) | 2010-09-06 | 2011-09-06 | Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner) |
Country Status (33)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI541246B (zh) | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH674618A5 (enExample) | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
| JP3238389B2 (ja) | 1988-10-27 | 2001-12-10 | シエーリング アクチエンゲゼルシヤフト | ゲストデン含有の経皮適用のための薬剤 |
| NZ240358A (en) | 1990-10-29 | 1994-09-27 | Alza Corp | Transdermal contraceptive device comprising (as active agents) an estrogen and a gestodene together with a skin permeation enhancer |
| US5512292A (en) | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| DE4210711A1 (de) | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
| DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE4405899A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Desogestrel |
| DE4405898A1 (de) | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| DE19629468A1 (de) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermale therapeutische Systeme |
| DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| DK1242012T3 (da) | 1999-11-24 | 2010-04-26 | Agile Therapeutics Inc | Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| TWI287455B (en) | 2000-12-05 | 2007-10-01 | Noven Pharma | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| EP1216699A1 (de) | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsystem enthaltend ein hochpotentes Gestagen |
| US20030165547A1 (en) * | 2001-05-18 | 2003-09-04 | Elisabeth Picard-Lesboueyries | Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA |
| DE10261696A1 (de) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
| MEP14008A (en) * | 2003-02-21 | 2010-06-10 | Bayer Schering Pharma Ag | Uv stable transdermal therapeutic plaster |
| UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
| US8668925B2 (en) * | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| KR101168449B1 (ko) * | 2003-12-12 | 2012-07-25 | 바이엘 파마 악티엔게젤샤프트 | 침투 증진인자가 필요없는 호르몬의 경피 전달계 |
| MX2007004315A (es) * | 2004-10-08 | 2008-03-11 | Noven Pharma | Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo. |
| DE102004062182B4 (de) | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff |
| US8962013B2 (en) * | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| DE102005050729A1 (de) | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| JP2012504609A (ja) * | 2008-10-06 | 2012-02-23 | マイラン・テクノロジーズ，インコーポレイテッド | アモルファスロチゴチン経皮システム |
-
2010
- 2010-09-06 DE DE102010040299A patent/DE102010040299A1/de not_active Withdrawn
-
2011
- 2011-02-09 UA UAA201304320A patent/UA110217C2/ru unknown
- 2011-09-02 EP EP11757808.8A patent/EP2613771A1/de not_active Withdrawn
- 2011-09-02 SG SG10201506927TA patent/SG10201506927TA/en unknown
- 2011-09-02 MY MYPI2013700339A patent/MY162768A/en unknown
- 2011-09-02 CN CN201180042701.6A patent/CN103079549B/zh not_active Expired - Fee Related
- 2011-09-02 PE PE2013000383A patent/PE20131138A1/es not_active Application Discontinuation
- 2011-09-02 JP JP2013526490A patent/JP6104800B2/ja not_active Expired - Fee Related
- 2011-09-02 WO PCT/EP2011/065204 patent/WO2012031985A1/de not_active Ceased
- 2011-09-02 EA EA201390246A patent/EA032575B1/ru not_active IP Right Cessation
- 2011-09-02 KR KR1020137008726A patent/KR20130114127A/ko not_active Ceased
- 2011-09-02 AP AP2013006787A patent/AP3586A/xx active
- 2011-09-02 PE PE2017001638A patent/PE20180198A1/es not_active Application Discontinuation
- 2011-09-02 NZ NZ607630A patent/NZ607630A/en not_active IP Right Cessation
- 2011-09-02 CU CU20130031A patent/CU24172B1/es active IP Right Grant
- 2011-09-02 MX MX2013002602A patent/MX2013002602A/es active IP Right Grant
- 2011-09-02 PH PH1/2013/500429A patent/PH12013500429A1/en unknown
- 2011-09-02 SG SG2013013453A patent/SG187941A1/en unknown
- 2011-09-02 BR BR112013005305A patent/BR112013005305A2/pt not_active Application Discontinuation
- 2011-09-02 CA CA2810103A patent/CA2810103C/en active Active
- 2011-09-02 AU AU2011298892A patent/AU2011298892B2/en not_active Ceased
- 2011-09-02 MA MA35706A patent/MA34581B1/fr unknown
- 2011-09-05 UY UY0001033590A patent/UY33590A/es unknown
- 2011-09-06 TW TW100132149A patent/TWI576245B/zh not_active IP Right Cessation
- 2011-09-06 AR ARP110103250A patent/AR082907A1/es unknown
- 2011-09-06 US US13/225,660 patent/US8557279B2/en not_active Expired - Fee Related
-
2013
- 2013-02-22 ZA ZA2013/01389A patent/ZA201301389B/en unknown
- 2013-02-28 IL IL224980A patent/IL224980A/en not_active IP Right Cessation
- 2013-03-05 TN TNP2013000087A patent/TN2013000087A1/fr unknown
- 2013-03-06 CO CO13045117A patent/CO6690753A2/es unknown
- 2013-03-06 CR CR20130098A patent/CR20130098A/es unknown
- 2013-03-06 EC ECSP13012477 patent/ECSP13012477A/es unknown
- 2013-03-06 CL CL2013000636A patent/CL2013000636A1/es unknown
- 2013-03-06 DO DO2013000053A patent/DOP2013000053A/es unknown
- 2013-03-06 GT GT201300062A patent/GT201300062A/es unknown
- 2013-09-17 US US14/028,990 patent/US9060955B2/en not_active Expired - Fee Related
-
2016
- 2016-08-22 JP JP2016161929A patent/JP2016216500A/ja active Pending
-
2017
- 2017-03-13 IL IL251124A patent/IL251124B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR115939A2 (es) | Composición que contiene palmitoil-etanolamida ultra-micronizada | |
| ES2578800T3 (es) | Módulo fotovoltaico que comprende un elemento de conversión espectral localizado y procedimiento de realización | |
| PE20120083A1 (es) | Sal monotosilato del compuesto 2-metil-2-[4-(3-metil-2-oxo-8-quinolin-3-il-2, 3-dihidro-imidazo-[4,5-c]-quinolin-1-il)-fenil]-propionitrilo en su forma cristalina a | |
| ES2646737T3 (es) | Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico | |
| IN2014CN00827A (enExample) | ||
| CL2009000533A1 (es) | Uso de una variante de defensina parenteral contra la tuberculosis; que comprende una sustitucion d9s en el polipeptido maduro; metodo para eliminar o inhibir mycobacterium in vitro. | |
| MX2012003588A (es) | Recubrimientos superficiales para la piel. | |
| AU2011336397A8 (en) | Chemokine CXCR4 receptor modulators and uses related thereto | |
| AR114086A2 (es) | Polvos para reconstitución | |
| MX2017000429A (es) | Lengüetas de sujecion. | |
| CL2013000735A1 (es) | Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico. | |
| PH12012501523A1 (en) | Dental strip for administration of oral treatment | |
| BR112014013878A8 (pt) | emplastro | |
| TW201129470A (en) | Surface protective sheet | |
| BR112015001621A2 (pt) | dispositivo de distribuição | |
| CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
| BR112012024585A2 (pt) | inibidores de pkc para o tratamento de linfomade células b tendo sinalização do receptor de células b ativas crônicas | |
| JP2015116730A5 (enExample) | ||
| AR085060A1 (es) | Composiciones para el tratamiento del cabello con un adhesivo acrilico sensible a la presion | |
| MY166972A (en) | Transdermal delivery system containing galantamine or salts thereof | |
| BR112013008578A2 (pt) | inibição do crescimento microbiano por inibição da aconitase | |
| GT201300062A (es) | Sistemas terapéuticos transdérmicos con lámina de protección (release liner) inhibidora de la cristalización | |
| CL2009000326A1 (es) | Forma de dosificacion unitaria que comprende una matriz de pelicula delgada que comprende un polimero de matriz soluble en agua y de 10ug a 200 ug de estradiol, o un hidrato o de un ester, con un espesor menor de 300 um, util en una condicion fisica causada por niveles endogenos insuficientes de estrogenos. | |
| MY170558A (en) | Non-crosslinkable adhesive composition and adhesive sheet | |
| JP2013536828A5 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |